IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS

Clinical trials for IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS explained in plain language.

Never miss a new study

Get alerted when new IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS trials appear

Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New ultrasound could spot heart danger in cancer patients

Diagnosis Not yet recruiting

This early-phase study tests whether a special ultrasound with a targeted contrast agent (Sonazoid) can quickly diagnose heart inflammation caused by immune checkpoint inhibitor cancer drugs. About 30 adults who recently received these drugs and show signs of heart inflammation w…

Matched conditions: IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS

Phase: EARLY_PHASE1 • Sponsor: University of Virginia • Aim: Diagnosis

Last updated Jun 12, 2026 12:06 UTC

IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS

Get alerted when new IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS trials appear

New ultrasound could spot heart danger in cancer patients